SEC Form 4 · accession 0001225208-26-006881
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & Group Pres, Cardiology
Period of report
Jul 31, 2026
Accepted (ET)
Aug 3, 2026 · 4:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 31, 2026 | I | 64,198 | $46.73 | A | 64,198 | I | By 401(k) |
| Common Stock | holding | — | — | — | 213,907 | D | ||
| Common StockF3 | holding | — | — | — | 5,234 | I | By Child |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
- F2Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- F3The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.